Patients with CML in the lymphoid blastic phase have inferior response to anti-CD19 CAR T-cell therapy compared to de novo Ph-positive B cell acute lymphoblastic leukemia

被引：0
|
作者：
Liu, Mei-Jing [1 ,2 ]
Tan, Kai-Wen [1 ,2 ]
Cao, Han-Yu [1 ,2 ]
Huang, Si-Man [1 ,2 ]
Qian, Chong-Sheng [1 ,2 ]
Xue, Sheng-Li [1 ,2 ]
Dai, Hai-Ping [1 ,2 ]
Gong, Wen-Jie [1 ,2 ]
机构：
[1] First Affiliated Hosp Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou 215006, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
来源：
HEMASPHERE | 2024年 / 8卷 / 02期
关键词：
FOLLOW-UP; DASATINIB; EFFICACY;
D O I：
10.1002/hem3.49
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing, P.
    Niu, Q.
    Deng, B.
    Liu, S.
    Wu, T.
    Gao, Z.
    Chang, A. H.
    Feng, X.
    Tong, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
  • [32] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Pan, Jing
    Niu, Qing
    Deng, Biping
    Liu, Shuangyou
    Wu, Tong
    Gao, Zhiyong
    Liu, Zhaoli
    Zhang, Yue
    Qu, Xiaomin
    Zhang, Yanlei
    Liu, Shaohui
    Ling, Zhuojun
    Lin, Yuehui
    Zhao, Yongqiang
    Song, Yanzhi
    Tan, Xiyou
    Zhang, Yan
    Li, Zhihui
    Yin, Zhichao
    Chen, Bingzhen
    Yu, Xinjian
    Yan, Ju
    Zheng, Qinlong
    Zhou, Xuan
    Gao, Jin
    Chang, Alex H.
    Feng, Xiaoming
    Tong, Chunrong
    LEUKEMIA, 2019, 33 (12) : 2854 - 2866
  • [33] Good Survival of CAR-T Cell Therapy Bridging to Allo-HSCT for Relapsed/Refractory Ph-Positive B-Cell Acute Lymphoblastic Leukemia
    Liu, Zhanxiang
    Wu, Tong
    Song, Yanzhi
    Yuan, Erhui
    Qin, Qishu
    Wang, Qi
    BLOOD, 2023, 142
  • [34] Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia Two case reports
    Zhu, Yang-min
    Wu, Zhao
    Tan, You-ping
    Du, Yuan-yuan
    Liu, Zhi
    Ou, Rui-ming
    Liu, Shuang
    Pu, Cheng-fei
    Jiang, Jing
    Wang, Jin-ping
    Xiao, Lei
    Zhang, Qing
    MEDICINE, 2016, 95 (51) : e5676
  • [35] NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY
    Yuen, Carlen
    Riedell, Peter
    Artz, Andrew
    Kosuri, Satyajit
    Kelly, Thomas
    Wu, Shasha
    Reder, Anthony
    Rezania, Kourosh
    Soliven, Betty
    Xie, Tao
    Mastrianni, James
    Park, Deric
    Klejch, Wesley
    Ali, Saad
    Bishop, Michael
    NEURO-ONCOLOGY, 2020, 22 : 126 - 126
  • [36] Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy
    Shang, Qianwen
    Wang, Yu
    Lu, Aidong
    Jia, Yueping
    Zuo, Yingxi
    Zeng, Huimin
    Zhang, Leping
    LEUKEMIA & LYMPHOMA, 2025, 66 (01) : 54 - 63
  • [37] Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy
    Zurko, Joanna C.
    Epperla, Narendranath
    Nizamuddin, Imran
    Torka, Pallawi
    David, Kevin A.
    Ollila, Thomas A.
    Hess, Brian T.
    Cohen, Jonathon B.
    Ferdman, Robert
    Liu, Jieqi
    Chowdhury, Sayan Mullick
    O'Shea, Kaitlyn
    Romancik, Jason
    Bhansali, Rahul
    Harris, Elyse
    Sorrell, Mckenzie
    Masel, Rebecca
    Fitzgerald, Lindsey
    Galvez, Carlos
    Ma, Shuo
    Winter, Jane N.
    Pro, Barbara
    Gordon, Leo I.
    Danilov, Alexey V.
    Stephens, Deborah M.
    Shah, Nirav N.
    Shouse, Geoffrey
    Kenkre, Vaishalee P.
    Barta, Stefan K.
    Karmali, Reem
    BLOOD, 2021, 138
  • [38] Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
    Saini, Neeraj
    Chang, Chia-Chi
    Strati, Paolo
    Nastoupil, Loretta J.
    Westin, Jason
    Nair, Ranjit
    Fayad, Luis
    Ahmed, Sairah
    Lee, Hun Ju
    Iyer, Swaminathan P.
    Steiner, Raphael Eric
    Greenbaum, Uri
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Jain, Nitin
    Green, Michael R.
    Ajami, Nadim J.
    Flowers, Christopher
    Champlin, Richard E.
    Wargo, Jennifer
    Neelapu, Sattva S.
    Jenq, Robert R.
    BLOOD, 2020, 136
  • [39] Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
    Colton, Meryl
    Purev, Enkhtsetseg
    Haverkos, Bradley
    Bair, Steven
    Jasem, Jagar
    Jacob, Allison
    Kamdar, Manali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 778 - 782
  • [40] Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia
    Breese, Erin H.
    Krupski, Christa
    Nelson, Adam S.
    Perentesis, John P.
    Phillips, Christine L.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : 152 - 154
12345